EN DE

Oceania Healthcare Limited (OCA) Fair Value & Analysis

Healthcare · AU · Market cap A$448M

OH Oceania Healthcare Limited OCA · AU
PriceA$0.6700
Fair ValueA$0.5600
Upside-16.4%
Quality48/100
Watch Oceania Healthcare Limited for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 0.0% net margin
Low debt · generates free cash flow
Trails peers (3/11)
Narrow moat 18/100
Evidence: High Range A$0.4100 – A$0.5600 Share as image

Fair value as of: Jul 14, 2026

From 14 valuation models · updated 27 days ago

Fair value updated Jul 14, 2026, revised from A$0.9700 to A$0.5600 (−42.3%) since Jun 24, 2026. Share price +8.9% over the past month.

Below-average quality, and screening another 16% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (A$0.5600). The favourable scenario is already priced in.
  • Solid but not exceptional quality (48/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

A$1.42 A$0.4750 Fair Value A$0.5600 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 14, 2026.

How to read this chart

60‑month range A$0.4750 – A$1.42 · fair‑value band A$0.4100 – A$0.5600 · the A$0.6700 price screens above the A$0.5600 fair value. Dashed = 300-day average. As of Jul 14, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Oceania Healthcare Limited (OCA) currently trades at A$0.6700, while our model-based Fair Value estimate is A$0.5600, implying the stock looks roughly 16.4% overvalued today. The Quality Score stands at 48/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Trailing-twelve-month revenue stands at A$269M. Revenue grew 7.6% year over year. Net debt stands at A$514M. Fundamentals as of Jul 14, 2026

Our scenario range runs from A$0.4100 (bear case) to A$0.5600 (bull case); at A$0.6700, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 18% below its 52-week high and 31% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at -16%, OCA screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF A$1.07 A$1.63 A$2.29 80
Residual Income A$1.03 A$0.9300 A$0.5500 76
Rev-Margin DCF A$0.4500 A$0.8800 A$1.31 74
All 14 models by family
DCF Models
FCF DCF A$1.04 A$1.66 A$2.42 38
5Y Revenue Exit A$0.4500 A$0.8500 A$1.32 39
5Y EBITDA Exit A$0.0600 A$0.1400 A$0.2200 41
5Y P/E Exit A$0.0300 A$0.0900 A$0.1400 38
10Y Revenue Exit A$0.6700 A$1.05 A$1.50 36
10Y EBITDA Exit A$0.4600 A$0.6100 A$0.7600 37
10Y P/E Exit A$0.4400 A$0.5800 A$0.7100 35
Dividend Discount
Gordon GGM A$0.0700 A$0.1200 A$0.1600 70
DDM Multi-Stage A$0.0700 A$0.1000 A$0.1300 61
Multiples
EV/Revenue A$0.0900 A$0.4200 A$0.7600 43
Asset-Based
NCAV (Graham) A$0.8200 A$1.10 A$1.64 50
Growth DCF
Growth DCF A$1.07 A$1.63 A$2.29 80
Rev-Margin DCF A$0.4500 A$0.8800 A$1.31 74
Economic Profit
Residual Income A$1.03 A$0.9300 A$0.5500 76

Widest divergence: Asset-Based (A$1.10) versus Dividend Discount (A$0.1000). Highest evidence: Growth DCF (80).

Notify me when OCA reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) A$269M
Revenue growth (YoY) +7.6%
Net margin 0.0%
Return on equity 0.0%
Free cash flow A$141M FY2026
Operating margin -6.0%
More key figures
EPS growth (YoY) +210%
Net debt A$514M FY2026

Figures from reported company fundamentals · as of Jul 14, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 48/100

Of which business quality 50 · Market factors (momentum, volatility) 47

Profitability 10
Margins and returns on capital today
Quality Growth 23
Are margins and returns improving?
Cashflow 97
Earnings quality: real cash, not paper profit
Fin. Strength 33
Balance sheet, leverage, solvency risk
Investment 68
Disciplined investing over empire-building
Low Volatility 61
Calm price path (market factor)
Momentum 40
Price trend over the last 3–12 months (market factor)
52W Momentum 43
Distance to the 52-week high (market factor)
Net Issuance 80
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Oceania Healthcare Limited, together with its subsidiaries, owns and operates retirement villages and care centres in New Zealand. The company operates through Care Operations, Village Operations, and Others segments.

Full company description

Oceania Healthcare Limited, together with its subsidiaries, owns and operates retirement villages and care centres in New Zealand. The company operates through Care Operations, Village Operations, and Others segments. It provides traditional care beds and care suites; independent living and rental properties; and rest home, hospital, and specialist dementia services. The company also offers accommodation, and care and related services to aged care residents, including meals and care packages to independent living residents; and accommodation and related services to independent residents in the retirement villages. In addition, it is involved in the provision of support services and training activities. The company was formerly known as Retirement Care (NZ) Limited and changed its name to Oceania Healthcare Limited in September 2014. Oceania Healthcare Limited was incorporated in 2005 and is based in Auckland, New Zealand.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Oceania Healthcare Limited reported revenue of A$269M in FY2026 versus A$231M in FY2022, a compound +3.9%/yr. Reported net income was A$119K in FY2026, compounding −79.0%/yr from FY2022.

Growth Quality 68/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2026)
A$269M
Latest YoY
+3.3%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.9%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.8%
Avg. growth/yr (13Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+3.0%
Revenue +3.9%/yr
FY22 A$231M
FY23 A$247M
FY24 A$265M
FY25 A$261M
FY26 A$269M
Net income −79.0%/yr
FY22 A$61.1M
FY23 A$15.4M
FY24 A$31.5M
FY25 A$30.4M
FY26 A$119K

OCA screens 16% overvalued. Compare with HCA Healthcare, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Oceania Healthcare Limited Fair Value". https://www.fairvalue-calculator.com/stock/OCA

Peer Group

Medical Care Facilities · 261 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 48 · Below median
Fair Value upside −16% · Below median
Return on equity (TTM) 0% · Below median
Return on assets -0% · Bottom 25%
Net margin (TTM) 0% · Below median
Operating margin (TTM) -6% · Bottom 25%
Revenue growth 8% · Above median
Debt / equity 0.44× · Higher than median

Valuation Multiples vs Medical Care Facilities median · lower = cheaper

P/B 0.27× · Cheaper than 75% of peers
P/S (TTM) 1.18× · Pricier than median
P/FCF 2.2× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 11 · sector 23
FUTURE 38 · sector 24
PAST 0 · sector 30
HEALTH 78 · sector 90
DIVIDEND 0 · sector 38

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 14, 2026).

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $378.85 $554.93 +46%
Fresenius SE FRE €41.73 €32.15 -23%
Dr. Sulaiman Al Habib Medical Services Group 4013 235.00 SAR 112.37 SAR -52%
IHH Healthcare Berhad, an investment holding company, Q0F 2.58 SGD 1.44 SGD -44%
Tenet Healthcare Corporation THC $194.91 $338.05 +73%
Rede D'Or São Luiz S.A RDOR3 R$36.01 R$47.31 +31%
DaVita Inc DVA $231.61 $255.97 +11%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,955 ₹2,955 -67%
Fresenius Medical Care AG FMS $24.68 $45.60 +85%
Aier Eye Hospital Group 300015 ¥8.68 ¥7.67 -12%

Compare Oceania Healthcare Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Oceania Healthcare Limited (OCA) overvalued or undervalued?
As of Jul 14, 2026, our model estimates a fair value of A$0.5600 versus a price of A$0.6700, about −16% (overvalued).
What is the fair value of OCA?
Our model-based fair value for Oceania Healthcare Limited is A$0.5600 (as of Jul 14, 2026), built from audited fundamentals. The current price is A$0.6700.
What is the quality score of OCA?
Oceania Healthcare Limited has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Oceania Healthcare Limited (OCA)?
Oceania Healthcare Limited reported trailing-twelve-month revenue of about A$269M (latest available figure, as of Jul 14, 2026).
What is the net profit margin of OCA?
The net profit margin of Oceania Healthcare Limited is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Oceania Healthcare Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.